TABLE 1.
lncRNAs | Expression | Biological function | Potential Targets | References |
---|---|---|---|---|
GAS5 | Down | Inhibit cell proliferation and invasion; Promote cell apoptosis; Inhibit paclitaxel, cisplatin, adriamycin and PI3K/mTOR inhibitor resistance | miR‐378a‐5p/SUFU, miR‐196a‐5p | 47, 48, 49, 108 |
LINC02095 | Up | Promote cell proliferation | SOX9 | 55 |
HOTAIR | Up | Promote cell migration and invasion; imatinib and lapatinib resistance | miR‐148a; LEF1/TCF4 | 92, 93, 109 |
WT1‐AS | Down | Inhibit cell migration and invasion | TGF‐β1 | 96 |
LINC00096 | Up | Promote cell proliferation and invasion | miR‐383‐5p/RBM3 | 50 |
DRHC | Down | Inhibit cell proliferation | HOTAIR | 60 |
HEIH | Up |
Promote cell proliferation Inhibit cell apoptosis |
miR‐4458/SOCS1 | 51 |
LUCAT1 | Up | Promote cell proliferation, cell cycle progression and metastasis; Inhibit cell apoptosis | miR‐5702 | 64 |
CCAT1 | Up | Promote cell proliferation, migration, and invasion | miR‐218/ZFX | 77 |
ASRPS | Down | Inhibit angiogenesis | STAT3 | 125 |
HAND2‐AS1 | Down | Inhibit cell proliferation | RUNX2 | 65 |
LINC01133 | Up | Promote cell stem cell (CSC)‐like phenotypic traits | KLF4 | 119 |
LINC01096 | Up | Promote cell proliferation, migration, and invasion; Inhibit cell apoptosis | miR‐3130‐3p | 97 |
PAPAS | Up | Promote cell migration and invasion | miR‐34a | 83 |
HCP5 | Up | Promote cell proliferation; Inhibit cell apoptosis | miR‐219a‐5p/BIRC3 | 52 |
NRAD1 | Up | Promote cell proliferation and CSC‐like phenotypic traits | ‐ | 122 |
LINK‐A | Up | Promote immunotherapy resistance; AKT inhibitors resistance; glycolysis reprogramming | PI3K/GPCR; Akt; HIF1α | 18, 110, 127 |
MIR503HG | Down | Inhibit cell migration and invasion | miR‐103/OLFM4 | 78 |
AWPPH | Up | Promote cell proliferation; Promote carboplatin resistance | miR‐21; FZD7 | 63, 112 |
PTCSC3 | Down | Inhibit cell proliferation | H19 | 61 |
NRON | Down | Inhibit cell proliferation | snaR | 62 |
sONE | Down | Inhibit cell proliferation, migration, and invasion | miR‐34a/15a/16, let‐7a, TP53/c‐Myc; NOS3 | 84, 85 |
NAMPT‐AS | Up | Promote cell metastasis | miR‐548b‐3p/ NAMPT | 79 |
DANCR | Up | Promote cell proliferation and invasion, and CSC‐like phenotypic traits | miR‐216a‐5p; RXRA; EZH2, CD44, ABCG2; Nanog, SOX2, and OCT4 | 56, 98, 120 |
NEAT1 | Up | Inhibit cell apoptosis; Promote cell cycle progression; Promote cisplatin and paclitaxel resistance and cancer stemness | ‐ | 75 |
TROJAN | Up | Promote cell proliferation and invasion | ZMYND8 | 17 |
POU3F3 | Up | Promote cell proliferation; Inhibit cell apoptosis | Caspase‐9 | 66 |
NEF | Down | Inhibit cell migration and invasion | miR‐155 | 99 |
ZEB2‐AS1 | Up | Promote cell proliferation, metastasis and EMT | ZEB2 | 88 |
LncKLHDC7B | Down | Inhibit cell migration and invasion; Promote cell apoptosis | KLHDC7B | 100 |
HIF1A‐AS2 | Up | Promote cell migration and invasion | ‐ | 101 |
LINC00339 | Up | Promote cell proliferation; Inhibit cell cycle arrest, apoptosis | miR‐377‐3p/HOXC6 | 53 |
LINC00152 | Up | Promote cell proliferation and invasion; Inhibit cell apoptosis | PTEN, BRCA1 | 57, 58 |
AFAP1‐AS1 | Up | Promote EMT | Wnt/β‐catenin | 81 |
PDCD4‐AS1 | Down | Inhibit cell proliferation and migration | PDCD4 | 59 |
HOST2 | Down | Inhibit cell proliferation | let‐7b/CDK6 | 54 |
BORG | Up | Promote doxorubicin resistance | RPA1 | 115 |
PVT1 | Up | Promote cell proliferation and migration, EMT | p21, KLF5/β‐catenin | 89, 90 |
H19 | Up | Promote paclitaxel resistance and CSC‐like phenotypic traits | Akt | 114, 123 |
TP73‐AS1 | Up | Promote cell vasculogenic mimicry | miR‐490‐3p/TWIST1 | 126 |
TUG1 | Down | Enhance cisplatin sensitivity | miR‐197/NLK | 113 |
MIR100HG | Up | Promote cell proliferation, Inhibit cell cycle arrest | p27 | 72 |
LINC01638 | Up | Promote cell proliferation, metastasis and CSC‐like phenotypic traits | c‐Myc | 121 |
ARNILA | Down | Promote EMT, invasion and metastasis | miR‐204/SOX4 | 91 |
LINC‐ZNF469‐3 | Up | Promote cell invasion, stemness properties and lung metastasis | miR‐574‐5p/ZEB1 | 87 |
ROR | Up | Promote cell invasion and metastasis | miR‐145/MUC1; miR‐145/ARF6 | 102, 103 |
AIRN | Down | Inhibit cell migration and invasion | Wnt/β‐catenin/mTOR/PI3K | 104 |
MANCR | Up | Promote cell proliferation, Inhibit DNA damage | ‐ | 128 |
RMST | Down | Inhibit cell proliferation, invasion and migration; Promote cell apoptosis, and regulate cell cycle. | ‐ | 76 |
SKAI1BC | Up | Promote cell migration and invasion | KAI1 | 105 |
ANRIL | Up | Promote cell proliferation, Inhibit cell apoptosis | miR‐199a | 67 |
MALAT1 | Up | Promote cell proliferation, cell cycle arrest, and invasion; Inhibit cell apoptosis | miR‐129‐5p; miR‐1/Slug; miR‐448/KDM5B | 68, 106, 149 |
SNHG12 | Up | Promote cell proliferation and migration, Inhibit cell apoptosis | MMP13 | 94 |
HULC | Up | Promote cell metastasis | MMP‐2, MMP‐9 | 107 |
SNAR | Up | Promote cell proliferation, migration and invasion | ‐ | 95 |
LINP1 | Up | Promote DNA DSB repair, and radiotherapy resistance | Ku80 | 117 |
PCAT6 | Up | radiotherapy resistance | miR‐185‐5p/TPD52 | 118 |